Quince Therapeutics Reports Q2 2026 Financial Results

What Happened

• Quince Therapeutics, Inc. (QNCX) announced its financial results for the quarter ended June 30, 2026 and provided recent business highlights. The company filed a Current Report on Form 8‑K on August 14, 2026 disclosing these updates.
• A press release detailing the results and highlights was furnished as Exhibit 99.1 to the 8‑K.

Key Details

• Filing date: August 14, 2026 (Form 8‑K, Item 2.02 — Results of Operations and Financial Condition).
• Period covered: Quarter ended June 30, 2026 (Q2 2026).
• Press release included as Exhibit 99.1 to the 8‑K.
• The filing also includes the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.

Why It Matters

• The 8‑K provides the latest quarterly results and business highlights that investors use to assess the company’s recent operating and financial performance (earnings, revenue and other metrics will be in the furnished press release).
• Because the press release is formally furnished to the SEC and the filing includes interactive XBRL data, investors and analysts can review the disclosed figures and importable data to update models or make informed decisions. For full financial details, refer to Exhibit 99.1 of the 8‑K.